Cancer Genetics, Inc.
(NASDAQ CM: CGIX)
Rigrodsky Law, P.A. is investigating Cancer Genetics, Inc. (“Cancer Genetics”) regarding possible breaches of fiduciary duties and other violations of law related to Cancer Genetics’ agreement to merge with StemoniX, Inc. ("StemoniX"). Under the terms of the agreement, Cancer Genetics will issue a number of shares of Cancer Genetics common stock to StemoniX shareholders.